• Navamedic issued its Norwegian Transparency Act statement for 2025, outlining human-rights and decent-work due diligence across its value chain.
• Risk screening identified 121 key suppliers: 4 high-risk, 34 medium-risk, 83 low-risk, largely driven by incomplete sustainability documentation.
• All tier-1 suppliers signed the supplier code of conduct; questionnaires cover ethics, labor standards, health and safety, environmental practices.
• Follow-ups target high- and medium-risk suppliers, seeking additional evidence; external supplier audit in 2025 reported no critical findings.
• No critical actual adverse human-rights or working-conditions impacts were identified during the 2025 due diligence process.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Navamedic ASA published the original content used to generate this news brief on August 13, 2026, and is solely responsible for the information contained therein.